U.S. markets closed

Schrödinger, Inc. (SDGR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
32.26+0.18 (+0.56%)
At close: 04:00PM EST
32.31 +0.05 (+0.16%)
After hours: 05:50PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Engulfing Line (Bearish)

Engulfing Line (Bearish)

Previous Close32.08
Bid32.30 x 1000
Ask33.35 x 800
Day's Range30.69 - 32.80
52 Week Range16.07 - 59.24
Avg. Volume787,938
Market Cap2.324B
Beta (5Y Monthly)1.58
PE Ratio (TTM)57.61
EPS (TTM)0.56
Earnings DateFeb 26, 2024 - Mar 01, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est47.20
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for SDGR

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Schrodinger, Inc.
    SDGR: What does Argus have to say about SDGR?SCHRODINGER INC has an Investment Rating of SELL; a target price of $25.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of Medium.
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
  • Business Wire

    Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

    NEW YORK, November 17, 2023--Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported that on November 13, 2023, the company granted (i) non-statutory stock options to purchase 14,400 shares of the company’s common stock to nine newly hired employees and (ii) restricted stock units (RSUs) with respect to 10,050 shares of the company’s common stock to 13 newly hired employees. These grants were m

  • InvestorPlace

    3 Cutting-Edge Biotech Stocks for the Bold Investor

    Ahead of what could be significant uncertainties in the market, investors may be better served with cutting-edge biotech stocks. Fundamentally, the reasoning centers on relative insulation. Of course, no sector is ever fully insulated from the equity sector’s ebb and flow. And even established blue chips may suffer volatility if the major indices print red ink. However, certain compelling biotech stocks to buy offer overwhelming relevance. Irrespective of economic conditions, society will likely

  • InvestorPlace

    AI Alert: 3 Healthcare Stocks That Are Investing in Artificial Intelligence

    We’re still in the initial stages of a massively disruptive artificial intelligence (AI) boom. Big Tech is investing billions of dollars into it. Grand View Research saying we could be looking at a $1.8 trillion opportunity by 2030. And so far, it’s changing just about everything about everything. That includes healthcare–which could create a $188 billion opportunity by 2030, according to analysts at Statista. Not only is AI assisting with diagnoses and clinical outcomes, but it’s also helping w